Capricor Therapeutics

News

Capricor sues partner Nippon Shinyaku in DMD therapy spat

Capricor has filed a lawsuit seeking to split from its commercial partner for Duchenne muscular dystrophy therapy, deramiocel, in the US.

News

Capricor files cell therapy for DMD cardiomyopathy with FDA

Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.

News

Young lonely man in a wheelchair on a balcony looking at the nature in the spring

Capricor preps phase 3 for Duchenne cell therapy as it seeks...

Capricor Therapeutics' bid to find a partner for its Duchenne muscular dystrophy (DMD) cell therapy CAP-1002 could get a boost after final phase 2 data showed a strong effect on disease pro

Capricor sues partner Nippon Shinyaku in DMD therapy spat

Capricor files cell therapy for DMD cardiomyopathy with FDA

Capricor preps phase 3 for Duchenne cell therapy as it seeks...

Zymeworks cuts deal to buy Theravance for $929m in cash

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks